China Resources Boya Bio-pharmaceutical Issues Sharp Profit Warning for 2025
China Resources Boya Bio-pharmaceutical, a key player in blood products and medical aesthetics, has sounded alarm bells with a stark profit warning for 2025. Expecting net profit attributable to
